Genmab Files Annual Report with the U.S. Securities and Exchange Commission
14/2 20:10
Media Release COPENHAGEN, Denmark; February 14, 2024 Genmab filed Form 20-F for the financial year 2023 with the U.S. SEC Genmab A/S (Nasdaq: GMAB) announced today that it has filed its Annual Report for the financial year 2023 on Form 20-F with the U.S....